Claims
- 1. A method of producing maize plants from maize microspores, comprising:
(a) selecting maize plant material comprising maize microspores at a developmental stage amenable to androgenic induction; (b) incubating the microspores in incubation medium at a temperature and osmolarity effective to induce androgenesis to obtain temperature-treated microspores; (c) isolating the temperature-treated microspores; (d) cultivating the isolated, temperature-treated microspores in cultivation medium with either at least one live plant ovary or ovary-conditioned medium to produce regenerative maize tissue, wherein the cultivation medium has an osmolarity between about 300 mOsm and about 500 mOsm and comprises at least one cytokinin and at least one auxin; and (e) regenerating maize plants from the regenerative maize tissue.
- 2. The method of claim 1, wherein the plant material comprises at least one of tassels, florets, and anthers.
- 3. The method of claim 1, wherein the microspores are in the late-uninucleate to early-binucleate developmental stage.
- 4. The method of claim 1, wherein the microspores are incubated in incubation medium at a temperature from about 1° C. above the freezing temperature of the incubation medium to about 17° C.
- 5. The method of claim 1, wherein the microspores are incubated in incubation medium at a temperature from about 4° C. to about 10° C.
- 6. The method of claim 1, wherein the microspores are incubated in incubation medium at a temperature from about 8° C. to about 10° C.
- 7. The method of claim 1, wherein the microspores are incubated in incubation medium for about 3 days to about 21 days.
- 8. The method of claim 1, wherein the microspores are incubated in incubation medium for about 7 days to about 15 days.
- 9. The method of claim 1, wherein the microspores are incubated in incubation medium for about 10 days to about 14 days.
- 10. The method of claim 1, wherein the incubation medium has an osmolarity between about 300 mOsm and about 450 mOsm.
- 11. The method of claim 1, wherein the incubation medium comprises at least one sporophytic development inducer.
- 12. The method of claim 11, wherein the at least one sporophytic development inducer is selected from the group consisting of 2-aminonicotinic acid; 2-chloronicotinic acid; 6-chloronicotinic acid; 2-chloroethyl-phosphonic acid; 2-hydroxynicotinic acid; 6-hydroxynicotinic acid; 3-hydroxypicolinic acid; Benzotriazole; 2-hydroxyproline; 2,2′-dipyridil; 2,4-pyridine dicarboxylic acid monohydrate; 2-hydroxypyridine; 2,3-dihydroxypyridine; 2,4-dihydroxypyrimidine-5-carboxylic acid; 2,4-dihydroxypyrimidine-5-carboxylic acid hydrate; 2-hydroxypirimidine hydrate; 2,4,5-trihydroxypyrimidine; 2,4,6-trichloropyrimidine; 2-hydroxy-4-methyl pyrimidine hydrochloride; 4-hydroxypyrazolo-3,4,d-pyrimidine; quinaldic acid; violuric acid monohydrate; thymine; xanthine; salicylic acid; sodium salicylate; salicyl aldehyde; salicyl hydrazide; 3-chlorosalicylic acid; fusaric acid; picolinic acid; butanediene monoxime; di-2-pyridyl ketone; salicin; 2,2′-dipyridil amine; 2,3,5-triiodobenzoic; 2-hydroxy-pyridine-N-oxide; 2-hydroxy-3-nitropyridine; benzotriazole carboxylic acid; salicyl aldoxime; glycine; D L-histidine; penicillamine; 4-chlorosalicylic acid; 6-aminonicotinic acid; 2,3,5,6-tetrachloride 4-pyridine carboxylic acid; alpha benzoin oxime; 2,3-butadiene dioxime; isonicotinic hydrazide; cupferron; ethyl xanthic acid; 3-hydroxy benzyl alcohol; salicyl amide; salicyl anhydride; salicyl hydroxamic acid; methyl picolinic acid; 2-chloro pyridine; 2,6-pyridine carboxylic acid; 2,3-pyridine dicarboxylic acid; 2,5-pyridine dicarboxylic acid; pichloram; ammonium thiocyanate; amiben; diethyl dithiocarbamate; glyphosate; anthranilic acid; thiourea; 2,4-diclorophenoxyacetic acid; 4-chloro anisole; 2,3-dichloroanisole; 2-(2,4)-dichlorophenoxy propionic acid; 2-(4-chlorophenoxy)-2-methyl propionic acid; 2-(para-chloro phenoxy) isobutyric acid and α,β-dichlorobutyric acid.
- 13. The method of claim 11, wherein the at least one sporophytic development inducer is 2-hydroxynicotinic acid.
- 14. The method of claim 11, wherein the concentration of the at least one sporophytic development inducer is from about 0.001 mg/l to about 1000 mg/l.
- 15. The method of claim 11, wherein the concentration of the at least one sporophytic development inducer is from about 1 mg/l to about 500 mg/l.
- 16. The method of claim 1, wherein the incubation medium is MMA′.
- 17. The method of claim 1, wherein the incubation medium is an aqueous medium comprising an amount of at least one nutrient that is less than the amount of that nutrient necessary for the optimal growth and development of the microspores in the aqueous medium.
- 18. The method of claim 1, wherein the temperature-treated microspores are isolated using density centrifugation.
- 19. The method of claim 18 wherein the density centrifugation utilizes a solution of mannitol layered over a solution of maltose, wherein the solution of maltose has a higher density than the solution of mannitol.
- 20. The method of claim 1, wherein the cultivation medium comprises sucrose and maltose.
- 21. The method of claim 1, wherein the cultivation medium is periodically refreshed to maintain an osmolarity of the cultivation medium between about 300 mOsm and about 500 mOsm.
- 22. The method of claim 1, wherein the at least one auxin is selected from the group consisting of 2,4-dichlorophenoxyacetic acid, indoleacetic acid, indolebutyric acid, naphthalene acetic acid, and phenylacetic acid.
- 23. The method of claim 22, wherein the at least one auxin is present at a concentration from about 0.01 mg/l to about 25 mg/l.
- 24. The method of claim 22, wherein the at least one auxin is present at a concentration from about 0.2 mg/l to about 10 mg/l.
- 25. The method of claim 22, wherein the at least one auxin is present at a concentration from about 1.2 mg/l to about 2.5 mg/l.
- 26. The method of claim 1, wherein the at least one cytokinin is selected from the group consisting of kinetin, benzaminopurine, and zeatin.
- 27. The method of claim 26, wherein the concentration of the at least one cytokinin is from about 0.01 mg/l to about 10 mg/l.
- 28. The method of claim 26, wherein the concentration of the at least one cytokinin is from about 0.2 mg/l to about 4 mg/l.
- 29. The method of claim 26, wherein the concentration of the at least one cytokinin is from about 0.5 mg/l to about 2 mg/l.
- 30. The method of claim 1, wherein the cultivation medium is IND.
- 31. The method of claim 1, wherein the at least one live ovary is a wheat ovary.
- 32. The method of claim 1, wherein the at least one live ovary is a barley ovary.
- 33. The method of claim 32, wherein the at least one live ovary is a barley cultivar Igri ovary.
- 34. The method of claim 1 wherein the cultivating step utilizes ovary-conditioned medium.
- 35. The method of claim 1, wherein the step of regenerating maize plants comprises the steps of:
(a) culturing the regenerative maize tissue in shoot regeneration medium to produce shoot-containing regenerative maize tissue, wherein the shoot regeneration medium comprises at least one cytokinin and at least one auxin; and (b) culturing the shoot-containing regenerative maize tissue in root regeneration medium to produce roots.
- 36. The method of claim 35, wherein the at least one cytokinin is kinetin.
- 37. The method of claim 35, wherein the concentration of the at least one cytokinin is 0.01 to 10 mg/l.
- 38. The method of claim 35, wherein the at least one auxin is napthalene acetic acid.
- 39. The method of claim 35, wherein the concentration of the at least one auxin is from about 0.01 mg/l to about 25 mg/l.
- 40. The method of claim 35, wherein the shoot regeneration medium is Reg-II.
- 41. The method of claim 35, wherein the root regeneration medium is Reg-III.
- 42. The method of claim 1, further comprising the step of transferring regenerative maize tissue to a competency medium prior to the maize plant regeneration step.
- 43. The method of claim 42, wherein the competency medium comprises at least one auxin.
- 44. The method of claim 42, wherein the competency medium is Reg-I.
- 45. The method of claim 1 further comprising the step of genetically transforming said microspores, the step of transformation being effected prior to the maize plant regeneration step.
- 46. Genetically transformed plants produced according to the method of claim 45.
- 47. A method of producing maize plants from maize microspores comprising:
(a) selecting maize tassels or florets comprising microspores at a developmental stage amenable to androgenic induction; (b) incubating the microspores in incubation medium with an effective amount of a sporophytic development inducer at around 8° C. to around 10° C. for about days to about 14 days to obtain temperature-treated microspores, wherein the incubation medium has an osmolarity between about 300 mOsm and about 450 mOsm and comprises 2-hydroxynicotinic acid; (c) isolating the temperature-treated microspores; (d) cultivating the isolated, temperature-treated microspores in cultivation medium with at least one live plant ovary to produce regenerative maize tissue, wherein the cultivation medium has an osmolarity between about 300 mOsm and about 500 mOsm and comprises kinetin, 2,4-dichlorophenoxyacetic acid, and phenylacetic acid; and (e) regenerating maize plants from the regenerative maize tissue.
- 48. A method of producing regenerative maize tissue from maize microspores, comprising:
(a) selecting maize plant material comprising maize microspores at a developmental stage amenable to androgenic induction; (b) incubating the microspores in incubation medium at a temperature and osmolarity effective to induce androgenesis to obtain temperature-treated microspores; (c) isolating the temperature-treated microspores; and (d) cultivating the isolated, temperature-treated microspores in cultivation medium with either at least one live plant ovary or ovary-conditioned medium to produce regenerative maize tissue, wherein the cultivation medium has an osmolarity between about 300 mOsm and about 500 mOsm and comprises at least one cytokinin and at least one auxin.
CROSS-REFERENCES TO RELATED APPLICATIONS
[0001] This application claims the benefit of priority to U.S. Provisional Application No. 60/260,028, filed on Jan. 5, 2001, under U.S.C. § 119, and is a continuation-in-part of U.S. application Ser. No. 09/383,588, filed Aug. 26, 1999, to which benefit of priority is claimed under 35 U.S.C. 120.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60260028 |
Jan 2001 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09383588 |
Aug 1999 |
US |
Child |
10037448 |
Jan 2002 |
US |